Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Okasa Pharma Private Limited, is an unlisted private company incorporated on 25 May, 1990. It is classified as a private limited company and is located in Mumbai-400 001.(Wef-27/8/2001), Maharashtra. It's authorized share capital is INR 10.50 cr and the total paid-up capital is INR 22.00 lac.
Okasa Pharma's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's book networth has decreased by 3.04%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2022 numbers.
21.53%
-3.04%
-3.05%
-1.11
32.4
6.34
-0.05
3.22
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Raman Parameswaran Athipotta
Shareholder
|
00025481 | 10 years |
| Director | Srinivas Hariharan | 00026785 | 22 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| OKASA PRIVATE LIMITED |
Amalgamated
|
5.3 Cr | 2 | Maharashtra |
| E-MAN CONSULTANTS PRIVATE LIMITED |
Amalgamated
|
62.0 L | 1 | Maharashtra |
| CIPLA NATURAL SCIENCES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ORION LIFE SCIENCES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| CIPLA LIFE SCIENCES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| MEDULE PHARMA PRIVATE LIMITED |
Converted to LLP
|
42.0 L | 1 | Maharashtra |
| DNA PHARMA PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| MEDICREAMS INDIA PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| DRUG DELIVERY SYSTEMS (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| METRO REMEDIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| METRO ADVISORS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| MN RAJKUMAR GARMENTS PVT LTD |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| SHREE RIDDHI CHEMICALS PVT LTD |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| ALPS REMEDIES PRIVATE LIMITED |
Active
|
20.2 L | 1 | Maharashtra |
| IRIS PROPERTIES PRIVATE LIMITED |
Amalgamated
|
60.0 L | 1 | Maharashtra |
| OMNICARE SPECIALITIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| NEPTUNE REMEDIES PRIVATE LIMITED |
Amalgamated
|
77.0 L | 1 | Maharashtra |
| DREAMZ IMPEX PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| HAMSONS LABORATORIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
40.0 L | 1 | Maharashtra |
| FLORAL FANTASY PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| CENTAUR EXPORTS PRIVATE LIMITED |
Amalgamated
|
66.8 L | 1 | Maharashtra |
| ADVANCED REMEDIES PRIVATE LIMITED |
Converted to LLP
|
3.0 Cr | 1 | Maharashtra |
| LABH CONSULTANTS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
2.5 Cr | 1 | Maharashtra |
| LABH CONSULTANTS LLP |
Active
|
2.5 Cr | 1 | Maharashtra |
| HEALINGCROSS PHARMA PRIVATE LIMITED |
Active
|
1.9 L | 1 | Maharashtra |
| INHALED TECHNOLOGIES PRIVATE LIMITED |
Converted to LLP
|
2.5 Cr | 1 | Maharashtra |
| NEBUMED PHARMA PRIVATE LIMITED |
Converted to LLP
|
3.8 Cr | 1 | Maharashtra |
| ONCOCARE INDIA PRIVATE LIMITED |
Converted to LLP
|
2.4 Cr | 1 | Maharashtra |
| OKASA GENERICS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| LANCET PHARMA PRIVATE LIMITED |
Converted to LLP
|
1.8 Cr | 1 | Maharashtra |
| PHARMASOLVE SPECIALITIES INDIA PRIVATE LIMITED |
Converted to LLP
|
1.0 Cr | 1 | Maharashtra |
| OKASA LABORATORIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| UNI WORLD PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| PROTEC LABORATORIES PVT LTD |
Strike Off
|
1.0 L | 1 | Maharashtra |
| GENIOUS SOLUTIONS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| MEDEX SPECIALITIES PRIVATE LIMITED |
Converted to LLP
|
75.6 L | 1 | Maharashtra |
| SYNERGY MEDICINES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| MEDIC REMEDIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| COMPASS PRODUCTIONS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| TWIST PHARMA PRIVATE LIMITED |
Strike Off
|
25.0 L | 1 | Maharashtra |
| CIPLA GLOBAL LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| NEO RESEARCH LABS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| MEDLAR LABORATORIES PRIVATE LIMITED |
Strike Off
|
6.0 L | 1 | Maharashtra |
| ORION LIFE SCIENCES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MEDICREAMS INDIA LLP |
Defunct
|
1.0 L | 1 | Maharashtra |
| DNA PHARMA LLP |
Active
|
1.0 L | 1 | Maharashtra |
| LANCET PHARMA LLP |
Strike Off
|
1.8 Cr | 1 | Maharashtra |
| ADVANCED REMEDIES LLP |
Active
|
3.0 Cr | 1 | Maharashtra |
| PHARMASOLVE SPECIALITIES INDIA LLP |
Active
|
1.0 Cr | 1 | Maharashtra |
| INHALED TECHNOLOGIES LLP |
Strike Off
|
2.5 Cr | 1 | Maharashtra |
| MEDIORALS LABORATORIES LLP |
Active
|
2.5 Cr | 1 | Maharashtra |
| ONE WORLD PHARMA LLP |
Active
|
9.0 L | 1 | Maharashtra |
The incorporation date of OKASA PHARMA PRIVATE LIMITED is 25 May, 1990
The authorized share capital of OKASA PHARMA PRIVATE LIMITED is INR ₹ 10.5 Cr.
The paid-up capital of OKASA PHARMA PRIVATE LIMITED is INR ₹ 22.0 L.
The registered address of OKASA PHARMA PRIVATE LIMITED is 12 GUNBOW STREET,,FORT,MUMBAI MUMBAI-400 001.(WEF-27/8/2001) Maharashtra - 400001
The CIN number of OKASA PHARMA PRIVATE LIMITED is U24239MH1990PTC071153.
Expand
Delete
Collapse
See
details
